Management of vasospastic disorders with botulinum toxin A.
about
Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and managementManagement of acute and chronic vascular conditions of the hand.Modification of blood vessel diameter following perivascular application of botulinum toxin-AProtective effect of botulinum toxin A after cutaneous ischemia-reperfusion injury.Botulinum Toxin Off-Label Use in Dermatology: A Review.Advances in the treatment of Raynaud's phenomenon.Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin aBotulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review.The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.A new treatment for frostbite sequelae; Botulinum toxin.25. Ischemic pain in the extremities and Raynaud's phenomenon.Hypothenar hammer syndrome: a case and brief review.The pathogenesis, diagnosis and treatment of Raynaud phenomenon.A vascular mechanistic approach to understanding Raynaud phenomenon.Improvement in both Raynaud disease and hyperhidrosis in response to botulinum toxin type A treatment.A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma.Clinical and image improvement of Raynaud's phenomenon after botulinum toxin type A treatment.Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.Outcomes of sympathectomy and vascular bypass for digital ischaemia in connective tissue disorders.Use of botox injection as a bridge in pediatric recurrent shoulder dislocations.Effect of botulinum toxin A on vasoconstriction and sympathetic neurotransmitters in a murine random pattern skin flap model.The mechanism of botulinum A on Raynaud syndrome.
P2860
Q28392431-9C499AB9-28C0-48B4-8E0D-0CB12D763DBDQ30360634-2D3A3667-F6D3-45CF-B66E-B50D86233D78Q30434923-17A7A4E8-BFB5-47E6-B6B7-2C207F9C240BQ33562360-9C392B68-E0D5-4246-A0A5-328B7765C2CBQ33781874-B0961558-5AA4-4493-9109-06C866C1A7E9Q33813778-201A462B-8E98-4651-A1C2-731882459868Q34995583-5F3DAD56-F715-408D-B33C-E9A2D8CD273CQ36091433-D36CA89D-F18E-4789-96ED-8CE05CA4F3EEQ36352392-378E946F-1A69-4211-B18C-CE7E35752539Q37669631-28528023-0E21-42C2-9CBB-6C35B16BF4D0Q37857369-6958E37A-601F-40F8-81AA-CE657189F3CBQ37968388-61C65CE6-C049-4C11-9FD1-109E4EBD0EF6Q38025285-1B572E54-E46B-4C6F-8B17-CBF0D3549E9BQ38299133-60F36183-5D05-47BF-A618-0C214A9F1E4CQ39853380-82FC8A5F-DC73-4008-B8E3-62DC8E80A61BQ40160181-078D9A1F-9898-428F-87B7-DF84ED50E0A6Q40267057-FADFFA3A-E1FF-4556-B375-63E039D4EEDAQ40296383-53246450-9E78-4075-B3B6-4BCDECDC302AQ40486294-8F141F7E-432B-4184-9C22-5258918C5E2BQ41872686-69597F07-312F-45F8-A1D4-6690D77976B5Q48133611-AD2F83DC-6B6D-4120-954D-AE94D3418302Q55517056-0802DBD9-BE45-4865-87FF-03D2DF06FFCC
P2860
Management of vasospastic disorders with botulinum toxin A.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Management of vasospastic disorders with botulinum toxin A.
@ast
Management of vasospastic disorders with botulinum toxin A.
@en
Management of vasospastic disorders with botulinum toxin A.
@nl
type
label
Management of vasospastic disorders with botulinum toxin A.
@ast
Management of vasospastic disorders with botulinum toxin A.
@en
Management of vasospastic disorders with botulinum toxin A.
@nl
prefLabel
Management of vasospastic disorders with botulinum toxin A.
@ast
Management of vasospastic disorders with botulinum toxin A.
@en
Management of vasospastic disorders with botulinum toxin A.
@nl
P2093
P1476
Management of vasospastic disorders with botulinum toxin A.
@en
P2093
Allen L Van Beek
Andrew J L Gear
Marc R Pritzker
Paul K Lim
P304
P356
10.1097/01.PRS.0000244860.00674.57
P407
P577
2007-01-01T00:00:00Z